Published :
Tables : 49
Figures : 45
Category : Healthcare
No. of Pages : 210
Report Code : HC-U3234
Respiratory Devices Market is predicted to value at a CAGR of over 8.8% during the forecast period 2022 to 2028. A respiratory device is a medical device used to help patients who have respiratory problems and cannot maintain adequate oxygen levels. Asthma, chronic obstructive pulmonary disease (COPD), chronic obstructive pulmonary infections (TBIs), and pneumonia are some respiratory diseases for which respiratory care devices are used to diagnose, monitor, and treat. As a result of these devices, patients suffering from acute and chronic respiratory diseases are able to receive improved care. As our global population ages, respiratory diseases are likely to become more prevalent. Chronic diseases, such as COPD and asthma, will also become more prevalent. This will lead to a continual increase in demand for respiratory devices. Patients with respiratory diseases have been using various devices in recent years that help remove mucus from the airways and improve pulmonary function. Global respiratory devices market growth is primarily driven by the high prevalence of respiratory diseases, aging populations around the globe, high prevalence of smoking, urbanization, pollution, preterm births on the rise, and lifestyle changes. As a result of infectious respiratory diseases, the demand for respiratory care directly increases. There is a significant impact on the anesthesia and respiratory devices market due to the increased incidence of respiratory diseases such as Chronic Obstructive Pulmonary Disease (COPD) and Obstructive Sleep Apnea (OSA). In the market, breathing apparatus dominates due to the high prevalence rate of respiratory diseases. As a result of the advanced equipment in the hospital, this segment is the most dominant. FutureWise Market Research has instantiated a report that provides an intricate analysis of Respiratory Devices Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market. According to the research study conducted by FutureWise research analysts, the Respiratory Devices Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical. Major players included in the Respiratory Devices Market: ResMed, Inc. Smiths Medical Fisher & Paykel Healthcare Limited Dragerwerk AG & Co. KGaA GE Healthcare Getinge AB Medtronic plc Koninklijke Philips N.V. Chart Industries Vyaire Medical, Inc. Karl Storz GmbH & Co. KG 3B Medical, Inc. Medline Industries Inc. Acare Technology Co., Ltd. Allied Healthcare Inc. (Note: The list of the major players will be updated with the latest market scenario and trends) Respiratory Devices Market Segmentation: By Type • Therapeutic Devices o Drug Delivery Devices o Nebulizers o Inhalers o Mechanical Ventilators o Invasive o Non-Invasive o Continuous Positive Airway Pressure o Devices o Disposables o Resuscitators o Reusable o Disposables o Humidifiers o Airway Clearance Devices o Oxygen Concentrators o Consumables & Disposables o Others • Diagnostic & Monitoring Devices o Pulse Oximeters o Capnographs o Spirometers o Polysomnographs o Peak Flow Meters o Gas Analyzers o Others By Application Chronic Obstructive Pulmonary Disease Asthma Obstructive Sleep Apnea Respiratory Distress Syndrome Cystic Fibrosis Pneumonia By End User • Hospitals/ Clinics • Homecare Settings • Other End-User By Region North America Europe Asia-Pacific Latin America Middle East and Africa Respiratory Devices Market Sample Video: Competitive Landscape: Tier 1 players- established companies in the market with a major market share Tier 2 players Emerging players which are growing rapidly New Entrants FutureWise Key Takeaways: Growth prospects SWOT analysis Key trends Key data-points affecting market growth Objectives of the Study: To provide with an exhaustive analysis on the Respiratory Devices Market By Type, By Application, By End user and By Region. To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement The customization Mobility Care offered are free of charge with purchase of any license of the report You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
A respiratory device is a medical device used to help patients who have respiratory problems and cannot maintain adequate oxygen levels. Asthma, chronic obstructive pulmonary disease (COPD), chronic obstructive pulmonary infections (TBIs), and pneumonia are some respiratory diseases for which respiratory care devices are used to diagnose, monitor, and treat. As a result of these devices, patients suffering from acute and chronic respiratory diseases are able to receive improved care. As our global population ages, respiratory diseases are likely to become more prevalent. Chronic diseases, such as COPD and asthma, will also become more prevalent. This will lead to a continual increase in demand for respiratory devices. Patients with respiratory diseases have been using various devices in recent years that help remove mucus from the airways and improve pulmonary function. Global respiratory devices market growth is primarily driven by the high prevalence of respiratory diseases, aging populations around the globe, high prevalence of smoking, urbanization, pollution, preterm births on the rise, and lifestyle changes. As a result of infectious respiratory diseases, the demand for respiratory care directly increases. There is a significant impact on the anesthesia and respiratory devices market due to the increased incidence of respiratory diseases such as Chronic Obstructive Pulmonary Disease (COPD) and Obstructive Sleep Apnea (OSA). In the market, breathing apparatus dominates due to the high prevalence rate of respiratory diseases. As a result of the advanced equipment in the hospital, this segment is the most dominant.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Respiratory Devices Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Respiratory Devices Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.
Major players included in the Respiratory Devices Market:
(Note: The list of the major players will be updated with the latest market scenario and trends)
Respiratory Devices Market Segmentation: By Type • Therapeutic Devices o Drug Delivery Devices o Nebulizers o Inhalers o Mechanical Ventilators o Invasive o Non-Invasive o Continuous Positive Airway Pressure o Devices o Disposables o Resuscitators o Reusable o Disposables o Humidifiers o Airway Clearance Devices o Oxygen Concentrators o Consumables & Disposables o Others • Diagnostic & Monitoring Devices o Pulse Oximeters o Capnographs o Spirometers o Polysomnographs o Peak Flow Meters o Gas Analyzers o Others
By Application
By End User • Hospitals/ Clinics • Homecare Settings • Other End-User
By Region
Respiratory Devices Market Sample Video:
Competitive Landscape:
FutureWise Key Takeaways:
Objectives of the Study:
Flexible Delivery Model:
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Respiratory Devices Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Respiratory Devices Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Respiratory Devices Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Respiratory Devices Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Therapeutic Devices 7.1.1. Drug Delivery Devices 7.1.1.1. Nebulizers 7.1.1.2. Inhalers 7.1.2. Mechanical Ventilators 7.1.2.1. Invasive 7.1.2.2. Non-Invasive 7.1.3. Continuous Positive Airway Pressure 7.1.3.1. Devices 7.1.3.2. Disposables 7.1.4. Resuscitators 7.1.4.1. Reusable 7.1.4.2. Disposables 7.1.5. Humidifiers 7.1.6. Airway Clearance Devices 7.1.7. Oxygen Concentrators 7.1.8. Consumables & Disposables 7.1.9. Others 7.2. Diagnostic & Monitoring Devices 7.2.1. Pulse Oximeters 7.2.2. Capnographs 7.2.3. Spirometers 7.2.4. Polysomnographs 7.2.5. Peak Flow Meters 7.2.6. Gas Analyzers 7.2.7. Others 8. Respiratory Devices Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Chronic Obstructive Pulmonary Disease 8.2. Asthma 8.3. Obstructive Sleep Apnea 8.4. Respiratory Distress Syndrome 8.5. Cystic Fibrosis 8.6. Pneumonia 9. Respiratory Devices Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Hospitals/ Clinics 9.2. Homecare Settings 9.3. Other End-User 10. North America Respiratory Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2022-2028 11. Latin America Respiratory Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. Brazil 11.2.2. Venezuela 11.2.3. Argentina 11.2.4. Rest of Latin America 11.3. Market Size (USD Million) Forecast for Latin America 2022-2028 12. Europe Respiratory Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Rest of Europe 12.3. Market Size (USD Million) Forecast for Europe 2022-2028 13. Asia Pacific Respiratory Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Japan 13.2.2. China 13.2.3. India 13.2.4. Australia and New Zealand 13.2.5. ASEAN 13.2.6. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 14. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. GCC 14.2.2. Israel 14.2.3. South Africa 14.2.4. Rest of MEA 14.3. Market Size (USD Million) Forecast for MEA 2022-2028 15. Market Share Analysis and Competitive Landscape 15.1. Global Landscape - Key Players, Revenue and Presence 15.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 15.3. Global Emerging Companies 15.4. North America - Market Share Analysis and Key Regional Players 15.5. Europe - Market Share Analysis and Key Regional Players 15.6. Asia Pacific - Market Share Analysis and Key Regional Players 15.7. Global Key Player - Growth Matrix 16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 16.1. ResMed, Inc. 16.1.1. Company Overview 16.1.2. Product Portfolio 16.1.3. SWOT Analysis 16.1.4. Financial Overview 16.1.5. Strategic Overview 16.2. Smiths Medical 16.2.1. Company Overview 16.2.2. Product Portfolio 16.2.3. SWOT Analysis 16.2.4. Financial Overview 16.2.5. Strategic Overview 16.3. Fisher & Paykel Healthcare Limited 16.3.1. Company Overview 16.3.2. Product Portfolio 16.3.3. SWOT Analysis 16.3.4. Financial Overview 16.3.5. Strategic Overview 16.4. Dragerwerk AG & Co. KGaA 16.4.1. Company Overview 16.4.2. Product Portfolio 16.4.3. SWOT Analysis 16.4.4. Financial Overview 16.4.5. Strategic Overview 16.5. GE Healthcare 16.5.1. Company Overview 16.5.2. Product Portfolio 16.5.3. SWOT Analysis 16.5.4. Financial Overview 16.5.5. Strategic Overview 16.6. Getinge AB 16.6.1. Company Overview 16.6.2. Product Portfolio 16.6.3. SWOT Analysis 16.6.4. Financial Overview 16.6.5. Strategic Overview 16.7. Medtronic plc 16.7.1. Company Overview 16.7.2. Product Portfolio 16.7.3. SWOT Analysis 16.7.4. Financial Overview 16.7.5. Strategic Overview 16.8. Koninklijke Philips N.V. 16.8.1. Company Overview 16.8.2. Product Portfolio 16.8.3. SWOT Analysis 16.8.4. Financial Overview 16.8.5. Strategic Overview 16.9. Chart Industries 16.9.1. Company Overview 16.9.2. Product Portfolio 16.9.3. SWOT Analysis 16.9.4. Financial Overview 16.9.5. Strategic Overview 16.10.Vyaire Medical, Inc. 16.10.1. Company Overview 16.10.2. Product Portfolio 16.10.3. SWOT Analysis 16.10.4. Financial Overview 16.10.5. Strategic Overview 16.11.Karl Storz GmbH & Co. KG 16.11.1. Company Overview 16.11.2. Product Portfolio 16.11.3. SWOT Analysis 16.11.4. Financial Overview 16.11.5. Strategic Overview 16.12.3B Medical, Inc. 16.12.1. Company Overview 16.12.2. Product Portfolio 16.12.3. SWOT Analysis 16.12.4. Financial Overview 16.12.5. Strategic Overview 16.13.Medline Industries Inc. 16.13.1. Company Overview 16.13.2. Product Portfolio 16.13.3. SWOT Analysis 16.13.4. Financial Overview 16.13.5. Strategic Overview 16.14.Acare Technology Co., Ltd. 16.14.1. Company Overview 16.14.2. Product Portfolio 16.14.3. SWOT Analysis 16.14.4. Financial Overview 16.14.5. Strategic Overview 16.15.Allied Healthcare Inc. 16.15.1. Company Overview 16.15.2. Product Portfolio 16.15.3. SWOT Analysis 16.15.4. Financial Overview 16.15.5. Strategic Overview 17. Pre and Post COVID-19 Impact 17.1. Positive influence on the healthcare industry 17.2. The financial disruption of the manufacturing sector 17.3. Impact of COVID-19 on emerging companies 17.4. Significant mandates in the regulations initiated by healthcare administrations 17.5. The overall economic slowdown of the developing and developed nations 18. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders
2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study
3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights
4. Respiratory Devices Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Respiratory Devices Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Respiratory Devices Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Respiratory Devices Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Therapeutic Devices 7.1.1. Drug Delivery Devices 7.1.1.1. Nebulizers 7.1.1.2. Inhalers 7.1.2. Mechanical Ventilators 7.1.2.1. Invasive 7.1.2.2. Non-Invasive 7.1.3. Continuous Positive Airway Pressure 7.1.3.1. Devices 7.1.3.2. Disposables 7.1.4. Resuscitators 7.1.4.1. Reusable 7.1.4.2. Disposables 7.1.5. Humidifiers 7.1.6. Airway Clearance Devices 7.1.7. Oxygen Concentrators 7.1.8. Consumables & Disposables 7.1.9. Others 7.2. Diagnostic & Monitoring Devices 7.2.1. Pulse Oximeters 7.2.2. Capnographs 7.2.3. Spirometers 7.2.4. Polysomnographs 7.2.5. Peak Flow Meters 7.2.6. Gas Analyzers 7.2.7. Others
8. Respiratory Devices Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Chronic Obstructive Pulmonary Disease 8.2. Asthma 8.3. Obstructive Sleep Apnea 8.4. Respiratory Distress Syndrome 8.5. Cystic Fibrosis 8.6. Pneumonia
9. Respiratory Devices Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Hospitals/ Clinics 9.2. Homecare Settings 9.3. Other End-User
10. North America Respiratory Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2022-2028
11. Latin America Respiratory Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. Brazil 11.2.2. Venezuela 11.2.3. Argentina 11.2.4. Rest of Latin America 11.3. Market Size (USD Million) Forecast for Latin America 2022-2028
12. Europe Respiratory Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Rest of Europe 12.3. Market Size (USD Million) Forecast for Europe 2022-2028
13. Asia Pacific Respiratory Devices Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Japan 13.2.2. China 13.2.3. India 13.2.4. Australia and New Zealand 13.2.5. ASEAN 13.2.6. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
14. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. GCC 14.2.2. Israel 14.2.3. South Africa 14.2.4. Rest of MEA 14.3. Market Size (USD Million) Forecast for MEA 2022-2028
15. Market Share Analysis and Competitive Landscape 15.1. Global Landscape - Key Players, Revenue and Presence 15.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 15.3. Global Emerging Companies 15.4. North America - Market Share Analysis and Key Regional Players 15.5. Europe - Market Share Analysis and Key Regional Players 15.6. Asia Pacific - Market Share Analysis and Key Regional Players 15.7. Global Key Player - Growth Matrix
16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 16.1. ResMed, Inc. 16.1.1. Company Overview 16.1.2. Product Portfolio 16.1.3. SWOT Analysis 16.1.4. Financial Overview 16.1.5. Strategic Overview 16.2. Smiths Medical 16.2.1. Company Overview 16.2.2. Product Portfolio 16.2.3. SWOT Analysis 16.2.4. Financial Overview 16.2.5. Strategic Overview 16.3. Fisher & Paykel Healthcare Limited 16.3.1. Company Overview 16.3.2. Product Portfolio 16.3.3. SWOT Analysis 16.3.4. Financial Overview 16.3.5. Strategic Overview 16.4. Dragerwerk AG & Co. KGaA 16.4.1. Company Overview 16.4.2. Product Portfolio 16.4.3. SWOT Analysis 16.4.4. Financial Overview 16.4.5. Strategic Overview 16.5. GE Healthcare 16.5.1. Company Overview 16.5.2. Product Portfolio 16.5.3. SWOT Analysis 16.5.4. Financial Overview 16.5.5. Strategic Overview 16.6. Getinge AB 16.6.1. Company Overview 16.6.2. Product Portfolio 16.6.3. SWOT Analysis 16.6.4. Financial Overview 16.6.5. Strategic Overview 16.7. Medtronic plc 16.7.1. Company Overview 16.7.2. Product Portfolio 16.7.3. SWOT Analysis 16.7.4. Financial Overview 16.7.5. Strategic Overview 16.8. Koninklijke Philips N.V. 16.8.1. Company Overview 16.8.2. Product Portfolio 16.8.3. SWOT Analysis 16.8.4. Financial Overview 16.8.5. Strategic Overview 16.9. Chart Industries 16.9.1. Company Overview 16.9.2. Product Portfolio 16.9.3. SWOT Analysis 16.9.4. Financial Overview 16.9.5. Strategic Overview 16.10.Vyaire Medical, Inc. 16.10.1. Company Overview 16.10.2. Product Portfolio 16.10.3. SWOT Analysis 16.10.4. Financial Overview 16.10.5. Strategic Overview 16.11.Karl Storz GmbH & Co. KG 16.11.1. Company Overview 16.11.2. Product Portfolio 16.11.3. SWOT Analysis 16.11.4. Financial Overview 16.11.5. Strategic Overview 16.12.3B Medical, Inc. 16.12.1. Company Overview 16.12.2. Product Portfolio 16.12.3. SWOT Analysis 16.12.4. Financial Overview 16.12.5. Strategic Overview 16.13.Medline Industries Inc. 16.13.1. Company Overview 16.13.2. Product Portfolio 16.13.3. SWOT Analysis 16.13.4. Financial Overview 16.13.5. Strategic Overview 16.14.Acare Technology Co., Ltd. 16.14.1. Company Overview 16.14.2. Product Portfolio 16.14.3. SWOT Analysis 16.14.4. Financial Overview 16.14.5. Strategic Overview 16.15.Allied Healthcare Inc. 16.15.1. Company Overview 16.15.2. Product Portfolio 16.15.3. SWOT Analysis 16.15.4. Financial Overview 16.15.5. Strategic Overview
17. Pre and Post COVID-19 Impact 17.1. Positive influence on the healthcare industry 17.2. The financial disruption of the manufacturing sector 17.3. Impact of COVID-19 on emerging companies 17.4. Significant mandates in the regulations initiated by healthcare administrations 17.5. The overall economic slowdown of the developing and developed nations
18. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics